Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging

American Journal of Epidemiology

Volumn 180, Issue 4, 2014, Pages 414-423

  Knopman, David S ^a   Roberts, Rosebud O ^a   Pankratz, V Shane ^a   Cha, Ruth H ^a   Rocca, Walter A ^a   Mielke, Michelle M ^a   Boeve, Bradley F ^a   Tangalos, Eric G ^a   Ivnik, Robert J ^b   Geda, Yonas E ^c   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

^b Department of Health Sciences Research   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Aging; Cognition; Cognitive aging; Dementia; Epidemiologic methods; Incidence; Prevalence

Indexed keywords

AGING; COGNITION; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH RISK; LONGITUDINAL GRADIENT; PARTICIPATORY APPROACH; SPATIOTEMPORAL ANALYSIS;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CHARLSON COMORBIDITY INDEX; CLINICAL DEMENTIA RATING; DEMENTIA; DIFFUSE LEWY BODY DISEASE; EPIDEMIOLOGY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HAZARD RATIO; HUMAN; INCIDENCE; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; PERSONALITY DISORDER; UNITED STATES; COGNITION; KAPLAN MEIER METHOD; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; REFUSAL TO PARTICIPATE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

MINNESOTA; OLMSTED COUNTY; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; COGNITION; DEMENTIA; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MILD COGNITIVE IMPAIRMENT; MINNESOTA; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES; REFUSAL TO PARTICIPATE;

EID: 84907303497     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu103     Document Type: Article

References (37)

1. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3): 201-209.
2. Tsuang D, Kukull W, Sheppard L, et al. Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. J Am Geriatr Soc. 1996; 44(6): 704-707.
3. Matthews F, Brayne C; Medical Research Council Cognitive Function and Ageing Study Investigators. The incidence of dementia in England andWales: findings from the five identical sites of the MRC CFA Study. PLoS Med. 2005; 2(8): e193.
4. Plassman BL, Langa KM, McCammon RJ, et al. Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol. 2011;70(3): 418-426.
5. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59(11): 1737-1746.
6. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(2): 195-204.
7. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60(2): 185-189.
8. Norton MC, Breitner JC, Welsh KA, et al. Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc. 1994;42(12): 1252-1256.
9. Launer LJ, Wind AW, Deeg DJ. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol. 1994;139(8): 803-812.
10. Roberts RO, Geda YE, Knopman DS, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008;30(1): 58-69.
11. Rocca WA, Yawn BP, St Sauver JL, et al. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012; 87(12): 1202-1213.
12. St Sauver JL, Grossardt BR, Yawn BP, et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173(9): 1059-1068.
13. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41(6): 1614-1624.
14. Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology. 2010;75(10): 889-897.
15. Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology. 2012;78(5): 342-351.
16. Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82(4): 317-325.
17. Knopman DS, Roberts RO, Geda YE, et al. Validation of the Telephone Interview for Cognitive Status-Modified in subjects with normal cognition, mild cognitive impairment, or dementia. Neuroepidemiology. 2010;34(1): 34-42.
18. Task Force on DSM-IV, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
19. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7): 939-944.
20. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2): 250-260.
21. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12): 1863-1872.
22. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6): 1546-1554.
23. Knopman D, Donohue JA, Gutterman EM. Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc. 2000;48(3): 300-304.
24. Jones RW, Mackell J, Berthet K, et al. Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: key findings of the Important Perspectives on Alzheimer's Care and Treatment (IMPACT) survey. J Nutr Health Aging. 2010;14(7): 525-530.
25. Buntinx F, Niclaes L, Suetens C, et al. Evaluation of Charlson's comorbidity index in elderly living in nursing homes. J Clin Epidemiol. 2002;55(11): 1144-1147.
26. Knopman DS, Petersen RC, Rocca WA, et al. Passive case-finding for Alzheimer's disease and dementia in two U.S. communities. Alzheimers Dement. 2011;7(1): 53-60.
27. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983; 39(2): 499-503.
28. St Sauver JL, Grossardt BR, Leibson CL, et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2): 151-160.
29. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 suppl 5): S10-S15.
30. Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-Analysis. Arch Gen Psychiatry. 1998;55(9): 809-815.
31. Jorm AF, Jolley D. The incidence of dementia: a meta-Analysis. Neurology. 1998;51(3): 728-733.
32. The Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology. 2000;55(1): 66-73.
33. Knopman DS, Petersen RC, Cha RH, et al. Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol. 2006;63(2): 218-221.
34. Edland SD, Rocca WA, Petersen RC, et al. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59(10): 1589-1593.
35. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148(6): 427-434.
36. Hebert LE,Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80(19): 1778-1783.
37. Knopman DS, Mosley TH, Catellier DJ, et al. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009; 5(3): 207-214.